Ivica Lukšić

2.3k total citations
82 papers, 820 citations indexed

About

Ivica Lukšić is a scholar working on Infectious Diseases, Oncology and Surgery. According to data from OpenAlex, Ivica Lukšić has authored 82 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 30 papers in Oncology and 29 papers in Surgery. Recurrent topics in Ivica Lukšić's work include COVID-19 Clinical Research Studies (25 papers), Salivary Gland Tumors Diagnosis and Treatment (16 papers) and Head and Neck Cancer Studies (15 papers). Ivica Lukšić is often cited by papers focused on COVID-19 Clinical Research Studies (25 papers), Salivary Gland Tumors Diagnosis and Treatment (16 papers) and Head and Neck Cancer Studies (15 papers). Ivica Lukšić collaborates with scholars based in Croatia, Poland and Ireland. Ivica Lukšić's co-authors include Mišo Virag, Darko Macan, Spomenka Manojlović, Marko Tarle, Marko Lucijanić, Bruno Baršić, M Mamic, Elźbieta Skrzydlewska, Neven Žarković and Mladen Petrovečki and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of neurosurgery and Annals of Oncology.

In The Last Decade

Ivica Lukšić

73 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivica Lukšić Croatia 17 356 319 157 151 145 82 820
Corey D. Kershaw United States 10 327 0.9× 241 0.8× 63 0.4× 107 0.7× 38 0.3× 24 515
Ziad E. Deeb United States 15 339 1.0× 176 0.6× 109 0.7× 48 0.3× 29 0.2× 33 822
Mitra Mehrad United States 20 358 1.0× 224 0.7× 68 0.4× 35 0.2× 25 0.2× 59 1.3k
D B Chang Taiwan 15 161 0.5× 191 0.6× 28 0.2× 17 0.1× 63 0.4× 19 748
Jinzhong Li China 11 117 0.3× 70 0.2× 62 0.4× 13 0.1× 29 0.2× 36 472
Vishal Rao India 11 152 0.4× 49 0.2× 91 0.6× 25 0.2× 30 0.2× 55 501
Angelo Ostuni Italy 12 168 0.5× 121 0.4× 79 0.5× 12 0.1× 22 0.2× 43 528
Rajeev Sharma United States 15 251 0.7× 54 0.2× 51 0.3× 12 0.1× 23 0.2× 67 532
C.J. Garvey United Kingdom 18 807 2.3× 714 2.2× 14 0.1× 11 0.1× 42 0.3× 42 1.2k
John A. Wirman United States 13 225 0.6× 361 1.1× 19 0.1× 70 0.5× 20 0.1× 24 820

Countries citing papers authored by Ivica Lukšić

Since Specialization
Citations

This map shows the geographic impact of Ivica Lukšić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivica Lukšić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivica Lukšić more than expected).

Fields of papers citing papers by Ivica Lukšić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivica Lukšić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivica Lukšić. The network helps show where Ivica Lukšić may publish in the future.

Co-authorship network of co-authors of Ivica Lukšić

This figure shows the co-authorship network connecting the top 25 collaborators of Ivica Lukšić. A scholar is included among the top collaborators of Ivica Lukšić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivica Lukšić. Ivica Lukšić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bočkor, Luka, Marko Tarle, Sanda Mustapić, et al.. (2025). Relationship Between Gut Microbiota and the Clinical Course of COVID-19 Disease. Viruses. 17(4). 520–520.
3.
Lucijanić, Marko, et al.. (2023). Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher C lostridioides difficile infection rate. Expert Opinion on Drug Safety. 22(12). 1265–1270.
4.
Skrzydlewska, Elźbieta, Wojciech Łuczaj, Michał Biernacki, et al.. (2023). Preliminary Comparison of Molecular Antioxidant and Inflammatory Mechanisms Determined in the Peripheral Blood Granulocytes of COVID-19 Patients. International Journal of Molecular Sciences. 24(17). 13574–13574.
6.
Tarle, Marko, et al.. (2023). Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 24(6). 5816–5816. 6 indexed citations
7.
Lucijanić, Marko, et al.. (2023). Predictors of prolonged hospitalization of COVID-19 patients. European Geriatric Medicine. 14(3). 511–516. 5 indexed citations
9.
Lucijanić, Marko, et al.. (2023). Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients. Life. 13(8). 1699–1699. 3 indexed citations
10.
Tarle, Marko, et al.. (2023). Retrospective Longitudinal Study on Changes in Atmospheric Pressure as a Predisposing Factor for Odontogenic Abscess Formation. Dentistry Journal. 11(2). 42–42. 2 indexed citations
11.
Mamic, M, et al.. (2023). Intranasal supernumerary tooth: two case reports and review of the literature. Acta Stomatologica Croatica. 57(4). 395–400. 1 indexed citations
12.
13.
Grgurević, Ivica, Marko Lucijanić, Tomislav Bokun, et al.. (2022). Short‐term outcomes of patients with chronic liver disease hospitalised with COVID‐19. Internal Medicine Journal. 52(11). 1891–1899. 6 indexed citations
14.
Vijay, Amrita, Frano Vučković, Irena Trbojević‐Akmačić, et al.. (2022). IgG N-glycome changes during the course of severe COVID-19: An observational study. EBioMedicine. 81. 104101–104101. 22 indexed citations
15.
Žarković, Neven, Lidija Milković, Bruno Baršić, et al.. (2021). Preliminary Findings on the Association of the Lipid Peroxidation Product 4-Hydroxynonenal with the Lethal Outcome of Aggressive COVID-19. Antioxidants. 10(9). 1341–1341. 35 indexed citations
16.
Skelin, Marko, et al.. (2021). De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research. European Archives of Oto-Rhino-Laryngology. 278(11). 4599–4603. 7 indexed citations
17.
Lukšić, Ivica, et al.. (2019). Management of accessory parotid gland tumours: 32-year experience from a single institution and review of the literature. International Journal of Oral and Maxillofacial Surgery. 48(9). 1145–1152. 11 indexed citations
18.
Lukšić, Ivica, et al.. (2012). Lymphatic drainage patterns of head and neck cutaneous melanoma: does primary melanoma site correlate with anatomic distribution of pathologically involved lymph nodes?. International Journal of Oral and Maxillofacial Surgery. 41(4). 413–420. 20 indexed citations
19.
Macan, Darko, et al.. (2008). Lipiodol ultra-fluid – foreign body in the cheek. Dentomaxillofacial Radiology. 37(3). 171–174. 4 indexed citations
20.
Ćabov, Tomislav, et al.. (2003). Oral inverted ductal papilloma. British Journal of Oral and Maxillofacial Surgery. 42(1). 75–77. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026